This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Colon Cancer Challenge Foundation Announces Date For 10th Anniversary Colon Cancer Challenge

RYE, N.Y., Jan. 28, 2013 /PRNewswire/ -- The Colon Cancer Challenge Foundation (CCCF), a nonprofit organization dedicated to reducing colorectal cancer incidence and death throughout the United States, today announced that its 2013 Colon Cancer Challenge in Central Park, New York City, will be held Sunday, April 7, 2013.  

The Colon Cancer Challenge® is the tri-state's premier colorectal cancer fundraising event designed to raise awareness and support for colorectal cancer research and prevention.  

"The Challenge not only helps spread the word about colorectal cancer, but it also helps raise funds for life-saving prevention and research programs to help eradicate colorectal cancer," said Dr. Thomas K. Weber, M.D., FACS, founder of the Colon Cancer Challenge Foundation, professor of surgery at the State University of New York at Downstate and chief of surgery at the Department of Veterans Affairs New York Harbor Healthcare System, Brooklyn Campus.

Participants can choose between three different walks or runs, including a 1.7-mile remembrance and prevention walk, 15K (9 miles) race or a shorter four-mile run. They can register for the Challenge at

This year is the 10th anniversary of the Colon Cancer Challenge. The event generated support from more than 10,000 participants and attendees last year. It provides an opportunity for those affected by colorectal cancer to recognize and remember loved ones and survivors.

The event is hosted by the Colon Cancer Challenge Foundation, which was started as an outgrowth of the original Challenge event by Weber. The foundation supports individuals and organizations that are leading innovative research programs for the prevention and cure of colorectal cancer. It also works to raise and disburse funds for programs that provide screening services to uninsured clients and assist them in obtaining services and support.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
FB $117.95 -0.52%
GOOG $695.00 -0.46%
TSLA $236.01 -2.40%
YHOO $36.10 -1.20%
AAPL $95.01 1.50%


Chart of I:DJI
DOW 17,737.89 -153.27 -0.86%
S&P 500 2,061.91 -19.52 -0.94%
NASDAQ 4,767.95 -49.6440 -1.03%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs